ADEF
Adams Diversified Equity Fund Portfolio holdings
AUM
$2.79B
1-Year Return
26.53%
This Quarter Return
+15.48%
1 Year Return
+26.53%
3 Year Return
+123.11%
5 Year Return
+224.03%
10 Year Return
+556.18%
AUM
$1.82B
AUM Growth
+$193M
(+12%)
Cap. Flow
-$21M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
26.7%
Holding
252
New
39
Increased
11
Reduced
130
Closed
33
Top Buys
| 1 |
Broadcom
AVGO
|
$18.5M |
| 2 |
Parker-Hannifin
PH
|
$17.4M |
| 3 |
American Express
AXP
|
$16.7M |
| 4 |
Texas Instruments
TXN
|
$16.6M |
| 5 |
Ulta Beauty
ULTA
|
$16.2M |
Top Sells
| 1 |
VanEck Semiconductor ETF
SMH
|
$15.8M |
| 2 |
Emerson Electric
EMR
|
$15.4M |
| 3 |
Biogen
BIIB
|
$14.7M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$14.4M |
| 5 |
Pfizer
PFE
|
$14.4M |
Sector Composition
| 1 | Technology | 18.52% |
| 2 | Financials | 17.17% |
| 3 | Healthcare | 14.91% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Industrials | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGN
201
DELISTED
Aegion Corp
AEGN
| $211K | 0.01% |
12,000
-12,800
| -52% | -$225K |
|
202
QuinStreet
QNST
$920M
| $206K | 0.01% |
15,400
-21,400
| -58% | -$286K |
|
203
Supernus Pharmaceuticals
SUPN
$2.58B
| $200K | 0.01% |
+5,700
| New | +$200K |
|
204
Ingles Markets
IMKTA
$1.34B
| $199K | 0.01% |
7,200
-7,600
| -51% | -$210K |
|
|
LCI
205
DELISTED
Lannett Company, Inc.
LCI
| $198K | 0.01% |
6,300
-14,100
| -69% | -$443K |
|
206
Chord Energy
CHRD
$5.92B
| $196K | 0.01% |
32,500
-7,400
| -19% | -$44.6K |
|
|
VGR
207
DELISTED
Vector Group Ltd.
VGR
| $194K | 0.01% |
26,627
-28,277
| -52% | -$206K |
|
|
DO
208
DELISTED
Diamond Offshore Drilling
DO
| $191K | 0.01% |
18,200
-6,600
| -27% | -$69.3K |
|
209
Trinseo
TSE
$88.1M
| $190K | 0.01% |
4,200
-4,400
| -51% | -$199K |
|
210
Matador Resources
MTDR
$6.01B
| $189K | 0.01% |
9,800
-10,400
| -51% | -$201K |
|
|
BSTC
211
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $187K | 0.01% |
3,000
-5,100
| -63% | -$318K |
|
212
Avient
AVNT
$3.45B
| $173K | 0.01% |
5,900
-6,200
| -51% | -$182K |
|
213
Emergent Biosolutions
EBS
$404M
| $162K | 0.01% |
3,200
-3,300
| -51% | -$167K |
|
214
Repligen
RGEN
$7.01B
| $160K | 0.01% |
+2,700
| New | +$160K |
|
215
Phibro Animal Health
PAHC
$1.6B
| $158K | 0.01% |
4,800
-5,000
| -51% | -$165K |
|
|
AMAG
216
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $152K | 0.01% |
11,800
-12,400
| -51% | -$160K |
|
217
Vanda Pharmaceuticals
VNDA
$272M
| $120K | 0.01% |
+6,500
| New | +$120K |
|
|
ARA
218
DELISTED
American Renal Associates Holdings, Inc
ARA
| $110K | 0.01% |
17,839
-18,900
| -51% | -$117K |
|
|
TLRD
219
DELISTED
Tailored Brands, Inc.
TLRD
| $101K | 0.01% |
12,900
-13,200
| -51% | -$103K |
|
220
AAR Corp
AIR
$2.71B
| – | – |
-13,500
| Closed | -$504K |
|
221
Allete
ALE
$3.69B
| – | – |
-7,800
| Closed | -$595K |
|
222
Alaska Air
ALK
$7.28B
| – | – |
-140,300
| Closed | -$8.54M |
|
223
ASGN Inc
ASGN
$2.32B
| – | – |
-8,100
| Closed | -$441K |
|
|
224
Biogen
BIIB
$20.6B
| – | – |
-48,900
| Closed | -$14.7M |
|
225
Cerus
CERS
$255M
| – | – |
-116,900
| Closed | -$593K |
|